Tempus AI (NASDAQ:TEM) Trading 1.1% Higher - Still a Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price traded up 1.1% during trading on Wednesday . The stock traded as high as $74.68 and last traded at $72.01. 9,626,059 shares changed hands during trading, a decline of 23% from the average session volume of 12,483,670 shares. The stock had previously closed at $71.21.

Analysts Set New Price Targets

TEM has been the subject of a number of research reports. TD Cowen reissued a "buy" rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. William Blair downgraded Tempus AI from an "outperform" rating to a "market perform" rating in a report on Wednesday, February 12th. Wolfe Research assumed coverage on Tempus AI in a research note on Friday, December 13th. They set an "outperform" rating and a $60.00 price target on the stock. Loop Capital cut their price target on Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research report on Tuesday, January 14th. Finally, Piper Sandler reissued a "neutral" rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $58.55.

Tempus AI Stock Up 6.8 %

The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm has a 50 day moving average of $47.46 and a two-hundred day moving average of $50.72.

Insider Buying and Selling at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the business's stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the sale, the insider now directly owns 16,164,449 shares in the company, valued at approximately $694,263,084.55. The trade was a 2.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Andrew Polovin sold 51,504 shares of the business's stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the sale, the executive vice president now directly owns 246,085 shares of the company's stock, valued at $10,431,543.15. This represents a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 2,401,779 shares of company stock valued at $115,707,361 over the last quarter.

Institutional Investors Weigh In On Tempus AI

Several institutional investors and hedge funds have recently modified their holdings of the stock. ARK Investment Management LLC raised its position in shares of Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock valued at $186,343,000 after purchasing an additional 3,141,487 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. lifted its stake in Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after buying an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after buying an additional 1,651,996 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.